Treatment of lung large cell neuroendocrine carcinoma-Reference-Cited by-同舟云学术

Treatment of lung large cell neuroendocrine carcinoma

Published:2016-03-04 Issue:6 Volume:37 Page:7047-7057
ISSN:1010-4283
Container-title:Tumor Biology
language:en
Short-container-title:Tumor Biol.

Author:

Lo Russo Giuseppe,Pusceddu Sara,Proto Claudia,Macerelli Marianna,Signorelli Diego,Vitali Milena,Ganzinelli Monica,Gallucci Rosaria,Zilembo Nicoletta,Platania Marco,Buzzoni Roberto,de Braud Filippo,Garassino Marina Chiara

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s13277-016-5003-4.pdf

Reference86 articles.

1. Travis WD, Rush W, Flieder DB, et al. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Am J Surg Pathol. 1998;22:934–44.

2. Iyoda A, Makino T, Koezuka S, et al. Treatment options for patients with large cell neuroendocrine carcinoma of the lung. Gen Thorac Cardiovasc Surg. 2014;62:351–6.

3. Su YH, Lin SW, Hsieh CC, et al. Treatment outcomes of patients with different subtypes of large cell carcinoma of the lung. Ann Thorac Surg. 2014;98:1013–9.

4. Liang R, Chen TX, Wang ZQ, et al. A retrospective analysis of the clinicopathological characteristics of large cell carcinoma of the lung. Exp Ther Med. 2015;9:197–202.

5. Paci M, Cavazza A, Annessi V, et al. Large cell neuroendocrine carcinoma of the lung: a 10-year clinicopathologic retrospective study. Ann Thorac Surg. 2004;77:1163–7.

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real world results of locally advanced and metastatic lung cancer patients treated with platinum doublet chemotherapy in first line: Moroccan cohort;Translational Oncology;2024-09

2. Advances in combined neuroendocrine carcinoma of lung cancer;Pathology and Oncology Research;2024-05-14

3. Prognostic factors and predictive models for patients with lung large cell neuroendocrine carcinoma: Based on SEER database;The Clinical Respiratory Journal;2024-04

4. Concomitant inhibition of PI3K/mTOR signaling pathways boosts antiproliferative effects of lanreotide in bronchopulmonary neuroendocrine tumor cells;Frontiers in Pharmacology;2024-02-05

5. Establishment and Validation of Prognostic Nomograms for Patients with Metastatic Pulmonary Large Cell Neuroendocrine Carcinoma;Cancer Control;2024-01